Fc variants
US-2026092115-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Katada Hitoshi patents
Katada Hitoshi is listed as an inventor on 42 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Katada Hitoshi |
| Total patents | 42 |
| First publication | Oct 22, 2015 |
| Latest publication | Apr 2, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Heterodimerized polypeptide
US-12371511-B2 · Jul 29, 2025 · US
Method for producing polypeptide hetero-oligomer
US-12359001-B2 · Jul 15, 2025 · US
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
US-2025076311-A1 · Mar 6, 2025 · US
Compositions comprising antigen-binding molecules
US-2024417464-A1 · Dec 19, 2024 · US
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
US-12169205-B2 · Dec 17, 2024 · US
Protease-activated cytokine
US-2024270806-A1 · Aug 15, 2024 · US
Compositions comprising antigen-binding molecules
US-12054544-B2 · Aug 6, 2024 · US
Heterodimer fc polypeptide
US-2024043515-A1 · Feb 8, 2024 · US
Heterodimer fc polypeptide
US-2023416371-A1 · Dec 28, 2023 · US
Recent patents
Latest publications not already listed above.
Method for altering plasma retention and immunogenicity of antigen-binding molecule
US-2023257470-A1 · Aug 17, 2023 · US
Method for altering plasma retention and immunogenicity of antigen-binding molecule
US-11718678-B2 · Aug 8, 2023 · US
Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY
US-2023174655-A1 · Jun 8, 2023 · US
ANTIGEN-BINDING MOLECULE FOR PROMOTING DISAPPEARANCE OF ANTIGEN VIA Fc GAMMA RIIB
US-2023140797-A1 · May 4, 2023 · US
Anti-ctla-4 antibody and use thereof
US-2023058982-A1 · Feb 23, 2023 · US
Fc REGION VARIANT
US-2022411483-A1 · Dec 29, 2022 · US
Protease substrate, and polypeptide including protease cleavage sequence
US-2022315909-A1 · Oct 6, 2022 · US
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
US-11454633-B2 · Sep 27, 2022 · US
Fc region variant
US-11267868-B2 · Mar 8, 2022 · US
Method for producing polypeptide hetero-oligomer
US-2022010030-A1 · Jan 13, 2022 · US
Method for producing polypeptide hetero-oligomer
US-11142587-B2 · Oct 12, 2021 · US
Method for producing polypeptide heteromultimer
US-11124576-B2 · Sep 21, 2021 · US
FCgammaRIIB-SPECIFIC FC REGION VARIANT
US-2021261648-A1 · Aug 26, 2021 · US
FcgammaRIIB-specific Fc region variant
US-10919953-B2 · Feb 16, 2021 · US
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
US-2020317768-A1 · Oct 8, 2020 · US
Heterodimerized polypeptide
US-10766960-B2 · Sep 8, 2020 · US
Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use
US-10738111-B2 · Aug 11, 2020 · US
Method for altering plasma retention and immunogenicity of antigen-binding molecule
US-2020199241-A1 · Jun 25, 2020 · US
Method for altering plasma retention and immunogenicity of antigen-binding molecule
US-10618965-B2 · Apr 14, 2020 · US
Pharmaceutical composition, antigen-binding molecules, treatment method, and screening method
US-2019382484-A1 · Dec 19, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Chugai Pharmaceutical Co Ltd | 42 |
| Igawa Tomoyuki | 2 |
| Mimoto Futa | 2 |
| Kuramochi Taichi | 2 |
| Katada Hitoshi | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/52 | 34 |
| A61K2039/505 | 30 |
| C07K2317/92 | 30 |
| A61P35/00 | 27 |
| C07K16/00 | 26 |